论文部分内容阅读
2011年我国中药注射剂市场规模约250亿-300亿元,复合增长率保持在30%左右,高于医药行业的平均增速。但近年来,多个品种的中药注射剂发生严重不良事件或存在严重不良反应而被停止生产或暂停销售使用,在2010年,国家食品药品监督管理局的不良药物反应报告中,中成药的不良反应排名前20,其中中药注射剂就占了17个。世代口服的中药在改用注射给药方式后,中药注射剂的研制、开发便
In 2011, the market size of Chinese medicine injections was approximately 25 billion to 30 billion yuan, and the compound growth rate remained at around 30%, which was higher than the average growth rate of the pharmaceutical industry. However, in recent years, a number of varieties of TCM injections have suffered serious adverse events or serious adverse reactions and were suspended from production or suspended for sale. In 2010, the State Food and Drug Administration reported adverse drug reactions to adverse reactions of proprietary Chinese medicines. In the top 20, Chinese medicine injections accounted for 17 of them. After the oral administration of traditional Chinese medicines was changed to injection, the preparation and development of traditional Chinese medicine injections was